EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Optogenetics: A Novel Therapeutic Avenue for Age-Related Macular Degeneration

Pier Luigi Grenga, Chiara Ciancimino iD, Alessandro Meduri, Serena Fragiotta iD

Biomolecules · 2025

DOI: 10.3390/biom15091286 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Pier Luigi Grenga und 3 weiteren Autor:innen. Beteiligte Einrichtung: UOC Ophthalmology, G.B. Grassi Hospital, Via Gian Carlo Passeroni, 28, Ostia, 00122 Rome, Italy. Hauptthemen laut MEDLINE: Optogenetics, Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the elderly, characterized by progressive degeneration of the retinal pigment epithelium (RPE) and photoreceptors in the macula. Current treatment options primarily focus on slowing disease progression in neovascular AMD, while effective therapies for dry AMD remain limited. Optogenetics, a revolutionary technique utilizing light-sensitive proteins (opsins) to control the activity of genetically targeted cells, has emerged as a promising therapeutic strategy for restoring vision in retinal degenerative diseases. In retinal disease models, adeno-associated viruses (AAVs) serve as delivery vectors via intravitreal or subretinal injections. This review explores the principles of optogenetics, its application in preclinical AMD models, and the potential for clinical translation of this approach. We discuss the various optogenetic tools, delivery methods, and the challenges and future directions in harnessing this technology to combat AMD-related vision loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OptogeneticsMacular DegenerationHumansAnimalsGenetic TherapyDependovirusRetinal Pigment Epithelium

Stichwörter der Autor:innen

adeno-associated viruses (AAVs)age-related macular degenerationoptogeneticstreatment

Autor:innen und Institutionen

  • UOC Ophthalmology, G.B. Grassi Hospital, Via Gian Carlo Passeroni, 28, Ostia, 00122 Rome, Italy.
  • Ophthalmology Unit, NESMOS Department, St. Andrea Hospital, "Sapienza" University of Rome, Via di Grottarossa 1035/1039, 00189 Rome, Italy.
  • Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, 98122 Messina, Italy.

ORCID-Profile: Chiara Ciancimino, Serena Fragiotta

Zitieren

APA

Grenga, P. L., Ciancimino, C., Meduri, A., & Fragiotta, S. (2025). Optogenetics: A Novel Therapeutic Avenue for Age-Related Macular Degeneration. Biomolecules. https://doi.org/10.3390/biom15091286

Vancouver

Grenga PL, Ciancimino C, Meduri A, Fragiotta S. Optogenetics: A Novel Therapeutic Avenue for Age-Related Macular Degeneration. Biomolecules. 2025. doi:10.3390/biom15091286

BibTeX
@article{Grenga2025,
  author = {Grenga, Pier Luigi and Ciancimino, Chiara and Meduri, Alessandro and Fragiotta, Serena},
  title = {Optogenetics: A Novel Therapeutic Avenue for Age-Related Macular Degeneration},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091286}
}
Kostenlos starten →